SCHEMBL25328375

SCHEMBL25328375

COc1cc(Nc2nccc(-c3cc(C(=O)O)n(C)n3)n2)cc(C(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 14/20 0.58
ZAP70 P43403 4/20 0.58
SRC P12931 3/20 0.58
JAK2 O60674 6/20 0.55
FLT3 P36888 5/20 0.55
MUSK O15146 1/20 0.55
NTRK1 P04629 1/20 0.55
PRKCB P05771 1/20 0.55
ROS1 P08922 1/20 0.55
PDGFRA P16234 1/20 0.55
FER P16591 1/20 0.55
PRKACA P17612 1/20 0.55
EIF2AK2 P19525 1/20 0.55
HIPK1 Q86Z02 1/20 0.55
MAP3K3 Q99759 1/20 0.55
CDK2 P24941 3/20 0.55
GSK3B P49841 3/20 0.55
CDK4 P11802 2/20 0.55
STK16 O75716 1/20 0.55
CLK1 P49759 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25328493 0.91 SYK (0.65) SYKJAK2FLT3LYN
SCHEMBL25327982 0.90 SYK (0.65) SYKZAP70SRCJAK2FLT3
SCHEMBL29492413 0.90 SYK (0.65) SYKZAP70SRCJAK2FLT3
SCHEMBL25328338 0.89 SYK (0.55) SYKZAP70SRCJAK2FLT3
SCHEMBL25327593 0.88 SYK (0.58) SYKZAP70JAK2FLT3MUSK
SCHEMBL25329614 0.85 SYK (0.67) SYKJAK2FLT3CDK2GSK3B
SCHEMBL25328502 0.84 SYK (0.66) SYKZAP70JAK2FLT3MUSK
SCHEMBL25328729 0.83 SYK (0.57) SYKZAP70SRCJAK2FLT3
SCHEMBL25328200 0.83 SYK (0.54) SYKZAP70JAK2FLT3MUSK
Hydrochloric Acid SCHEMBL29492275 0.82 SYK (0.70) SYKZAP70SRCJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240285621-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2024-08-29 US disclosed
EP-4217354-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2023-08-02 EP disclosed
CN-116323595-A Pyrazolyl-pyrimidine derivatives as kinase inhibitors 内尔维亚诺医疗科学公司 2023-06-23 CN disclosed
WO-2022063646-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240285621-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS SYK, LCK, BTK SYK 1/4885ZAP70 4/4885SRC 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.